• Hakan Yiğitbaş, Erkan Yavuz, Evrim Beken Özdemir, Onder Onen, Halime Hanim Pençe, Serhat Meriç, Atilla Çelik, Fatih Çelebi, Ahmet Cinar Yasti, Tansel Sapmaz, Aydın Zilan, and Mustafa Turan.
• Department of General Surgery, Health Sciences University Bağcılar Training and Research Hospital, İstanbul-Turkey.
• Ulus Travma Acil Cer. 2019 Sep 1; 25 (5): 520-526.

BackgroundThis research aims to retrospectively evaluate the effectiveness and safety of dermal substitute (DS), Nevelia®, for the treatment of severely burned patients.MethodsTwenty severely burned patients were enrolled in this study between May 2017 and May 2018. After escharotomy of the wound, the treatment protocol was applied following a two-step procedure -DS implantation followed by split-thickness skin graft (STSG) application. Need for surgery, complications, hospitalisation duration and overall survival were analysed.ResultsMean age was 40.1±4 (18-86) years old; female/male: 5/15. Mean burn surface area was 50.1%±2 (25-96). Two patients died under hospital treatment due to the severity of their burn trauma and comorbidities. For the rest of the cases, STSG was performed after Nevelia® at mean 21.2 days. No complications due to Nevelia® were detected. The patients were discharged with a mean total recovery of 55.2±4 days.ConclusionThis study showed that Nevelia® can be used safely and effectively in severely burned patients with low complication rates and short hospital stay.

16 keywords...

hide…